Coherus Oncology receives Nasdaq bid price deficiency notice; 180 days to regain compliance

Coherus Oncology, Inc.

On June 30, 2025, Nasdaq notified Coherus that its common stock closed below $1.00 for 30 consecutive business days.
Company has until December 29, 2025 to regain compliance by closing at $1.00+ for 10 consecutive days.
If not compliant by deadline, Coherus may qualify for an additional 180-day period by transferring to Nasdaq Capital Market.
Failure to cure could lead to delisting; company intends to monitor bid price and evaluate options.

item 3.01

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.